Methylprednisolone
Showing 1 - 25 of 1,561
Post-COVID-19 Syndrome Trial in Berlin (Methylprednisolone)
Not yet recruiting
- Post-COVID-19 Syndrome
- Methylprednisolone
-
Berlin, GermanyCharité - Universitätsmedizin Berlin
Aug 9, 2023
Knee Arthritis Trial in Atlanta, Tucker (Methylprednisolone, Standard of Care)
Not yet recruiting
- Knee Arthritis
- Methylprednisolone
- Standard of Care
-
Atlanta, Georgia
- +1 more
May 5, 2023
Cyanotic Heart Disease, Cardiopulmonary Bypass Trial in Karachi (Methylprednisolone, Saline)
Recruiting
- Cyanotic Heart Disease
- Cardiopulmonary Bypass
- Methylprednisolone
- Saline
-
Karachi, Sindh, PakistanAga Khan University Hospital
Jun 30, 2023
Caudal Block Trial (caudal block using dexamethasone, caudal block using methylprednisolone)
Not yet recruiting
- Caudal Block
- caudal block using dexamethasone
- caudal block using methylprednisolone
- (no location specified)
Jan 28, 2023
Carpal Tunnel Syndrome Trial in Knin (5% dextrose injection, 5% dextrose injections with methylprednisolone acetate 40 mg/ml)
Recruiting
- Carpal Tunnel Syndrome
- 5% dextrose injection
- 5% dextrose injections with methylprednisolone acetate 40 mg/ml
-
Knin, CroatiaGeneral and Veteran Hospital "Croatian Pride" Knin
Sep 13, 2023
Toxic Epidermal Necrolysis Trial in Fuzhou (Abrocitinib)
Recruiting
- Toxic Epidermal Necrolysis
-
Fuzhou, Fujian, ChinaDepartment of Dermatology, the First Affiliated Hospital of Fuji
Oct 31, 2023
Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics
Completed
- Kidney Transplant Patients
- Combined with voriconazole
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Qianfoshan Hospital
Sep 12, 2023
Toxic Optic Neuropathy, Treatment, Methylprednisolone Trial in Ciudad de mexico (Recombinant human erythropoietin 4,000 UI and
Recruiting
- Toxic Optic Neuropathy
- +3 more
- Recombinant human erythropoietin 4,000 UI and 2,000 UI
- Methylprednisolone succinate 500 mg
-
Ciudad de mexico, MexicoJorge Cárdenas Belaunzarán
Feb 20, 2023
Methylprednisone Administration, Intranasal Administration, Intravenous Administration Trial in Mexico City (Evaluation of
Completed
- Methylprednisone Administration
- +3 more
- Evaluation of bioavailability of methylprednisolone succinate administered intravenously
- Evaluation of bioavailability of methylprednisolone succinate administered intranasally
-
Mexico City, MexicoUniversidad Nacional Autonoma de Mexico
Dec 13, 2022
Multiple Sclerosis Trial in Clermont-Ferrand (Methylprednisolone, Placebo, natalizumab (NTZ))
Recruiting
- Multiple Sclerosis
- Methylprednisolone
- +3 more
-
Clermont-Ferrand, FranceCHU Clermont-Ferrand
Jan 5, 2023
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Tampa (High Dose Methylprednisolone (HDMP), Ofatumumab,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- High Dose Methylprednisolone (HDMP)
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 12, 2023
Lupus Nephritis, Remission, Safety Issues Trial in Nanjing (Methylprednisolone Injectable Suspension, Belimumab Injection,
Recruiting
- Lupus Nephritis
- +2 more
- Methylprednisolone Injectable Suspension
- +2 more
-
Nanjing, Jiangsu, ChinaJiong Zhang
May 8, 2023
Total Knee Arthroplasty Trial in Oak Brook (Methylprednisolone, Placebo)
Recruiting
- Total Knee Arthroplasty
- Methylprednisolone
- Placebo
-
Oak Brook, IllinoisRush Oak Brook Outpatient Center
Nov 15, 2022
NSCLC Trial in Guangzhou (chest radiation, concurrent chemo, Methylprednisolone)
Terminated
- Non-small Cell Lung Cancer
- chest radiation
- +2 more
-
Guangzhou, Guangdong, ChinaSun yat-sen University Cancer Center
Nov 25, 2022
Acute GVHD Trial (Itolizumab, Methylprednisolone)
Not yet recruiting
- Acute Graft Versus Host Disease
- Itolizumab
- Methylprednisolone
- (no location specified)
Apr 10, 2023
Idiopathic Pulmonary Fibrosis Trial in Assiut (Azithromycin, Methylprednisolone)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- Azithromycin
- Methylprednisolone
-
Assiut, EgyptAssiut university-Faculty of Medicine
May 2, 2023
Inflammation, Pain, Postoperative, Trismus Trial in Granada (Dexamethasone 4 Mg/mL Injectable Solution, MethylPREDNISolone 40
Recruiting
- Inflammation
- +2 more
- Dexamethasone 4 Mg/mL Injectable Solution
- MethylPREDNISolone 40 Mg/mL Injectable Suspension
-
Granada, SpainUnai Fernández Martín
Feb 28, 2023
Knee Osteoarthritis Trial (ACP Max™, Depo-Medrol®)
Not yet recruiting
- Knee Osteoarthritis
- ACP Max™
- Depo-Medrol®
- (no location specified)
Mar 1, 2023
Heart Block, Aortic Stenosis, Bundle-Branch Block Trial in Alicante (Methylprednisolone, Placebo)
Recruiting
- Heart Block
- +2 more
- Methylprednisolone
- Placebo
-
Alicante, SpainGeneral University Hospital of Alicante
Oct 3, 2023
Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica
- Efgartigimod
- Intravenous methylprednisolone (IVMP) and Efgartigimod
- IVMP
- (no location specified)
Nov 1, 2023
Methylprednisolone, Glucocorticoid, Aortic Dissection Trial (Methylprednisolone Injection)
Recruiting
- Methylprednisolone
- +3 more
- Methylprednisolone Injection
-
Shanghai, Shanghai, ChinaZhongshan Hospital
Oct 25, 2022
Pneumonitis, Malignant Tumor Trial in Guangzhou (Pirfenidone, methylprednisolone, Methylprednisolone)
Recruiting
- Pneumonitis
- Malignant Tumor
- Pirfenidone, methylprednisolone
- Methylprednisolone
-
Guangzhou, Guangdong, ChinaZhou Chengzhi
Mar 6, 2022
Methylprednisolone, Thoracic Endovascular Repair, Post-implantation Syndrome Trial (methylprednisolone, physiological saline)
Not yet recruiting
- Methylprednisolone
- +3 more
- methylprednisolone
- physiological saline
- (no location specified)
Apr 21, 2022
Elective Cardiac Surgery Trial in Ghent (Methylprednisolone, Placebo)
Completed
- Elective Cardiac Surgery
- Methylprednisolone
- Placebo
-
Ghent, BelgiumUniversity Hospital Ghent
Dec 6, 2022